Communications publiées lors de congrès ou colloques nationaux et internationaux (39)
Rapports de recherche, comptes rendus, lettres à l'éditeur, working papers (1)
Participations à des congrès et colloques internationaux (50)
1.
Melchior, M., Van Eycken, M., Nicaise, C., Duquesne, T., Longueville, L., Decaestecker, C., Salmon, I., Delporte, C., & Soyfoo, M. S. (2023). Aquaporin expression in lupus nephritis: insights into tubular pathology [poster]. Annals of the Rheumatic Diseases,(82), 5406.2.
Lebrun, L., Melendez Asensio, B., Blanchard, O., De Nève, N., De Clercq, S., Balsat, C., Riva, M., De Witte, O., Balériaux, D., Brotchi, J., Bruneau, M., Decaestecker, C., D'Haene, N., & Salmon, I. (2019). Morphological And Molecular Characterization Of Intramedullary Astrocytomas. Journal of neuropathology and experimental neurology,(78), 19 (p.525).4.
Gevaert, T., Van Eycke, Y.-R., De Ridder, D., Salmon, I., Rorive, S., Claessens, F., Vandenbroeck, T., Van Poppel, H., Decaestecker, C., & Joniau, S. (2018). A multivariate survival analysis of tumour micro-environment markers reveals an independent prognostic subgroup in matched prostate cancer cohorts.(17(2)), e160 Abstract session presented at 33rd Annual EAU Congress(16-20 March 2018: Copenhagen, Denmark).6.
Bienfait, L., Doukoure, B., D'Haene, N., Salmon, I., Decaestecker, C., Demetter, P., & Verset, L. (2017). Mismatch repair deficient colorectal cancer: comparison of an Ivory Coast with a Belgian cohort. Poster présenté à la conférence Belgian Week Pathology 2017 (19-21/10/2017: Gent, Belgium.).7.
Gevaert, T., Van Eycke, Y.-R., Vandenbroeck, T., De Ridder, D., Van Poppel, H., Claessens, F., Rorive, S., Salmon, I., Decaestecker, C., & Joniau, S. (2017). TMPRSS2-ERG differentiates towards low-grade prostate cancer but is not an independent predictor for clinical outcome. Virchows Archiv,(471), S273.8.
Gevaert, T., Van Poppel, H., Claessens, F., Salmon, I., Rorive, S., Decaestecker, C., Van Eycke, Y.-R., De Ridder, D., & Joniau, S. (2017). Steroid hormone receptors are differently expressed in prostate cancer depending on Gleason grade and presence of disease recurrence. European Urology Supplements. Vol. 16 (pp. e252-e253) Abstract session presented at 32nd Annual EAU Congress(March 2017: London).9.
Trepant, A.-L., D'Haene, N., Allard, J., Van Eycke, Y.-R., Decaestecker, C., Salmon, I., & Demetter, P. (2016). Vascular Insulin-Like Growth Factor Receptor Type 2 (IGF2R) Expression is Upregulated in Malignant Tumours. The Journal of Pathology, Volume 240, Issue Supplement S1 (p. 22) Abstract session presented at Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland(9th: 28 June – 1 July 2016: Nottingham).